• SIGN IN
  • GET HELP
  •  

    Webinar Details


    Event Type

    Live Online

    Date

    Wednesday, August 10, 2022

    Time

    10:30 AM - 11:30 AM ET

    Location

    PharmCon Webinar Studio (freeCE.com)

    Credits

    1 Contact Hour(s)

    Target Audience

    Pharmacist, Pharmacy Technician, Nurse

    Cost

    $30.00

    • Overview

      It's time for a drug bracketology, a “Drug Madness,” to pit one drug against another. With absolutely no room for bias, pharmacology will rule as law of the land to ultimately crown “The Most Interesting Drug of All Time.” We’ll start with a “Sweet 16” of substances of abuse, mention a few bubble-busting first four out, and navigate our way through the “Elite 8” and “Final 4,” all while reviewing patient counseling-specific pharmacology clinical pearls. One drug will remain standing atop the mountain. We will also discuss more detail into the sensationalized actual “drug madness” permeating through our society in the “War on Drugs" including, but also well beyond, the "Opioid Crisis.”


      Handouts

      Slide Document 22152L99_2pp.pdf
      Slide Document 22152L99_6pp.pdf





      Financial Support By

      PharmCon
    • Pharmacist

      Recall the classifications of all substances of abuse in respect to mechanisms of action and effects
      Identify opportunities for patient counseling centered on substances of abuse including side effects, interactions, and general concerns
      Recall past and recent national drug overdose trends

      Pharmacy Technician

      Recall the classifications of all substances of abuse in respect to mechanisms of action and effects
      Identify opportunities for patient counseling centered on substances of abuse including side effects, interactions, and general concerns
      Recall past and recent national drug overdose trends

      Nurse

      Recall the classifications of all substances of abuse in respect to mechanisms of action and effects
      Identify opportunities for patient counseling centered on substances of abuse including side effects, interactions, and general concerns
      Recall past and recent national drug overdose trends
    • Repeat Presentation

      This presentation was last given on 7/5/2022 10:30 AM

      Future Airings

      Date Time
      Friday, September 16, 2022 10:30 AM View
      Wednesday, October 19, 2022 10:30 AM View

    • Activity Type

      Knowledge

      CE Broker

      20-917177

      Universal Activity Number

      Pharmacist 0798-0000-22-152-L99-P

      Pharmacy Technician 0798-0000-22-152-L99-T

      Nurse 0798-0000-22-152-L99-N

      ACPE PharmCon is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

      PharmCon, Inc. is an approved course provider for continuing education for nurses by the Florida Board of Nursing. PharmCon is also recognized by the California Board of Nursing as a provider of nursing programs.

      In order to obtain a Statement of Credit, attendees must respond to all randomly-generated participation checks and complete a program evaluation. Attendees may immediately print their Statement of Credit or leave them stored on the website.


    HARDWARE REQUIREMENTS
    Windows 8.1
    Windows 10
    Apple Mac OS X 10.13 or higher
    iOS 10+
    Android 4.3+


    SOFTWARE REQUIREMENTS
    Google Chrome
    Mozilla Firefox

    Log in locally; do not log in using a VPN, cloud server, remote desktop, etc.


    NETWORK REQUIREMENTS
    Broadband Internet Connection:
    T1, Hi-speed DSL or Cable
    4G cellular connection
     
     

    This continuing education activity is held as copyright by PharmCon. Through this notice, PharmCon. grants permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).




    Computer sharing is NOT permitted due to accreditation guidelines on activity monitoring. Credit is earned by one user per device.